Botanical species · safety record

Peucedanum praeruptorum

The EFSA Compendium of Botanicals holds 8 constituent measurements for Peucedanum praeruptorum. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Peucedanum praeruptorum Dunn

8Constituent measurements
0Safety records
6Cited sources
126Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 126 licensed products naming Peucedanum praeruptorum as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry
  • Extract Type TBA

Source material stated

  • Dried root(s)
  • New material
  • Peucedanum praeruptorum root
  • Root

What the records describe

Constituents measured

  • Coumarins5
  • Falcarindiol1
  • Isoscopoletin1
  • Umbelliferone1

Plant parts

  • Roots and other underground parts7
  • Aerial part of plants1

Preparations

  • Solvent extraction8

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
CoumarinsRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
CoumarinsRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
FalcarindiolAerial part of plantsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
CoumarinsRoots and other underground partsSolvent extractionUnspecifiedNo resolvable identifier
CoumarinsRoots and other underground partsSolvent extraction0.59 PercentGelpermeation, High Performance Thin Layer Chromatography (HPTLC)No resolvable identifier
CoumarinsRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)No resolvable identifier
IsoscopoletinRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)No resolvable identifier
UmbelliferoneRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Kong, LY., Min, ZD., Li, Y., Li, X., Pei, YH. Qianhucoumarin I from Peucedanum praeruptorum. PHYTOCHEMISTRY, 1996, vol. 42, no. 6, p. 1689-1691. DOI
  2. Wang, C., Chang, TH., Zhang, XH., Wang, HL. Effects of dl-praeruptorin A on nucleus factor-kappa B and tumor necrosis factor-alpha expression in ischemia-reperfusion hearts . Acta pharmacologica sinica, 2004, vol. 25, no. 1, p. 35-40.
  3. Kong, LY., Li, Y., Min, ZD., Li, X., Zhu, TR. Coumarins from Peucedanum praeruptorum. PHYTOCHEMISTRY, 1996, vol. 41, no. 5, p. 1423-1426.
  4. Miyazawa, M., Shimamura, H., Bhuva, RC., Nakamura, S., Kameoka, H. Antimutagenic activity of falcarindiol from Peucedanum praeruptorum. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 1996, vol. 44, no. 11, p. 3444-3448. DOI
  5. Ishii, Hirotaka., Okada, Yoshihito., Baba, Masaki., Okuyama, Toru. Studies of coumarins from the Chinese drug Qianhu, XXVII: Structure of a new simple coumarin glycoside from Bai-Hua Qianhu, Peucedanum praeruptorum. CHEMICAL & PHARMACEUTICAL BULLETIN, 2008, vol. 56, no. 9, p. 1349-1351. DOI
  6. Zhang, Xiuqin., Xu, Lixin. Determination of coumarins in Qian Hu. Zhongyao tongbao, 1984, p. 79-81.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue